DOSE OF REALITY: NEW ANALYSES UNDERSCORE HOW BIG PHARMA’S EGREGIOUS PRICING OF WEIGHT LOSS DRUGS IS UNSUSTAINABLE

Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of Big Pharma’s Out-of-Control Prices on GLP-1s Two new analyses released Wednesday highlight how the egregious prices

04-25-2024 Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Big Pharma Giant Kicks Off Q1 Earnings After Hiking Prices More Than 40 Times in 2023 This week, brand name drug giant Johnson & Johnson kicked off the first round of Big Pharma earnings calls

04-19-2024 Read More

SECOND OPINION: BIG PHARMA’S OUT-OF-POCKET PLANS ON BRAND NAME INHALERS MAY BE DESIGNED TO FURTHER UNDERMINE COMPETITION

Big Pharma’s Announcements Designed to Deflect from Criticism and Scrutiny for Years of Egregious Anti-Competitive and Pricing Practices on Brand Name Inhalers Under increasing scrutiny from

04-8-2024 Read More

CSRXP COMMENDS PRESIDENT BIDEN FOR HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE AND EGREGIOUS PRICING ON BRAND NAME INHALERS

President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press Conference Highlighting Big Pharma’s Anti-Competitive Practices and Price Hikes on Inhalers Washington, D.C. – The

04-3-2024 Read More

Dose of Reality: CBO Confirms Big Pharma’s Egregious Prices on Weight Loss Drugs Are Unsustainable

CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings from “Reducing Other Health Care Spending” In case you missed it, the Congressional Budget Office (CBO) recently

03-22-2024 Read More

THEN VS. NOW: PFIZER LATEST BIG PHARMA GIANT TO ACCIDENTALLY DEBUNK INDUSTRY’S OWN DOOM-AND-GLOOM INNOVATION RHETORIC

Big Pharma Exec Downplays “Modest” Drug Pricing Solutions That CEO Previously Claimed Would Reduce R&D and Called “Gun to Your Head” Big Pharma can’t seem to keep its story straight.

03-7-2024 Read More

BIG PHARMA WATCH: BIG PHARMA SET NEW RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2023, UP 35 PERCENT FROM PREVIOUS YEAR

Median Price Set by Brand Name Drug Makers on New Treatments Climbs to $300,000 In case you missed it, on Friday, Reuters released a new analysis which found that the median annual price among new

02-26-2024 Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY AND NOVO NORDISK

GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023, Hike Prices on at Least 20 Brand Name Products in First Weeks of 2024 Big Pharma giants Eli Lilly and Novo Nordisk

02-22-2024 Read More

BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB AND ABBVIE

More Big Pharma Giants Report Earnings That Top Wall Street Expectations While Continuing to Hike Prices on Dozens of Brand Name Drugs Merck, Bristol Myers Squibb

02-15-2024 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.